EP3215193
Skömmtunaráætlun fyrir pegýlerað interferón
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
6.11.2015EP published:
4.10.2023EP application number:
15857703.1
EP translation filed:
18.12.2023Grant published:
15.1.2024EPO information:
European Patent Register
Max expiry date:
5.11.2035Expiry date:
5.11.2026Next due date:
30.11.2026
Title in English:
DOSAGE REGIMEN FOR PEGYLATED INTERFERONLanguage of the patent:
English
Timeline
Today
6.11.2015EP application
4.10.2023EP Publication
18.12.2023Translation submitted
15.1.2024Registration published
5.11.2026Expires
Owner
Name:
PharmaEssentia CorporationAddress:
13F, No. 3 Park (YuanQu) Street Nangang District, Taipei City 11503, TW
Inventor
Name:
KLADE, ChristophAddress:
1160 Vienna, AT
Name:
ZAGRIJTSCHUK, OlehAddress:
1160 Vienna, AT
Name:
LIN, Ko-ChungAddress:
Lexington, MA 02421, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
14192114Date:
6.11.2014Country:
EP
Classification
Categories:
A61K 38/21, A61K 47/60, A61P 35/00, A61P 7/00, A61P 19/00, A61P 19/04, A61P 19/08, A61P 31/00, A61P 35/02
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 20.12.2023
Expires: 5.11.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 10
Paid: 12.11.2024
Expires: 5.11.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 11
Paid: 11.11.2025
Expires: 5.11.2026
Payer: G.H. Sigurgeirsson ehf.